HUP0104568A3 - Human prostatic cell lines for cancer treatment - Google Patents

Human prostatic cell lines for cancer treatment

Info

Publication number
HUP0104568A3
HUP0104568A3 HU0104568A HUP0104568A HUP0104568A3 HU P0104568 A3 HUP0104568 A3 HU P0104568A3 HU 0104568 A HU0104568 A HU 0104568A HU P0104568 A HUP0104568 A HU P0104568A HU P0104568 A3 HUP0104568 A3 HU P0104568A3
Authority
HU
Hungary
Prior art keywords
cell lines
cancer treatment
human prostatic
prostatic cell
human
Prior art date
Application number
HU0104568A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Onyvax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyvax Ltd filed Critical Onyvax Ltd
Publication of HUP0104568A2 publication Critical patent/HUP0104568A2/hu
Publication of HUP0104568A3 publication Critical patent/HUP0104568A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/884—Vaccine for a specifically defined cancer prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HU0104568A 1998-12-10 1999-12-09 Human prostatic cell lines for cancer treatment HUP0104568A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9827104.2A GB9827104D0 (en) 1998-12-10 1998-12-10 New cancer treatments
PCT/GB1999/004129 WO2000033869A2 (en) 1998-12-10 1999-12-09 Use of human prostrate cell lines in cancer treatment

Publications (2)

Publication Number Publication Date
HUP0104568A2 HUP0104568A2 (hu) 2002-03-28
HUP0104568A3 true HUP0104568A3 (en) 2004-05-28

Family

ID=10843926

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104568A HUP0104568A3 (en) 1998-12-10 1999-12-09 Human prostatic cell lines for cancer treatment

Country Status (19)

Country Link
US (3) US6972128B1 (enExample)
EP (1) EP1137422B1 (enExample)
JP (2) JP4949554B2 (enExample)
KR (1) KR20010090874A (enExample)
AT (1) ATE304365T1 (enExample)
AU (1) AU763485B2 (enExample)
CA (1) CA2354045C (enExample)
CZ (1) CZ300499B6 (enExample)
DE (1) DE69927286T2 (enExample)
ES (1) ES2249046T3 (enExample)
GB (1) GB9827104D0 (enExample)
HU (1) HUP0104568A3 (enExample)
IL (2) IL143296A0 (enExample)
MX (1) MXPA01005816A (enExample)
NO (1) NO327044B1 (enExample)
NZ (1) NZ512004A (enExample)
PL (1) PL201016B1 (enExample)
WO (1) WO2000033869A2 (enExample)
ZA (1) ZA200104164B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9827104D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
GB9827103D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
AU4935700A (en) * 1999-05-21 2000-12-12 Onyvax Limited New vaccine formulations-3
CA2404388C (en) * 2000-04-01 2010-06-15 Onyvax Limited New prostate cell lines
US6667479B2 (en) * 2001-06-01 2003-12-23 Raytheon Company Advanced high speed, multi-level uncooled bolometer and method for fabricating same
US20050019336A1 (en) 2003-07-23 2005-01-27 Dalgleish Angus George Human prostate cell lines in cancer treatment
WO2005023328A2 (en) * 2003-08-26 2005-03-17 Becton Dickinson And Company Methods for intradermal delivery of therapeutics agents
CN105664147A (zh) * 2007-02-07 2016-06-15 日本电气株式会社 用于癌症的治疗剂
US20100255020A1 (en) * 2007-11-20 2010-10-07 Nec Corporation Method for inducing cytotoxic t-cells, cytotoxic t-cell inducers, and pharmaceutical compositions and vaccines employing them
AU2009200767A1 (en) * 2008-03-10 2009-09-24 Aristocrat Technologies Australia Pty Limited A gaming system and a method of gaming
CA2743904A1 (en) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE230615T1 (de) * 1991-10-04 2003-01-15 Whitehead Biomedical Inst Regulierung der systemischen immunantworten mittels zytokinen und antigenen
JPH05246889A (ja) * 1992-03-05 1993-09-24 Seitai Chiyousetsu Kenkyusho:Kk 制癌方法および制癌剤
WO1995029704A1 (en) * 1994-04-28 1995-11-09 Scott Freeman Cell lines obtained by in vivo migration and by fusion with autoimmune cells
JP3201610B2 (ja) * 1995-03-17 2001-08-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 腫瘍を処置する方法
US5788963A (en) * 1995-07-31 1998-08-04 Pacific Northwest Cancer Foundation Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
ES2191784T3 (es) * 1995-12-28 2003-09-16 Univ Johns Hopkins Med Vacunas de tumores de citocinas paracrinas alogenicas.
EP0877798B1 (en) * 1996-02-02 2003-05-07 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer
GB9620350D0 (en) * 1996-09-30 1996-11-13 Maudsley David J Cancer vaccine
US6207805B1 (en) * 1997-07-18 2001-03-27 University Of Iowa Research Foundation Prostate cell surface antigen-specific antibodies
GB9827104D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments

Also Published As

Publication number Publication date
US8034360B2 (en) 2011-10-11
ZA200104164B (en) 2002-01-24
WO2000033869A2 (en) 2000-06-15
CA2354045A1 (en) 2000-06-15
PL348828A1 (en) 2002-06-17
JP2012021028A (ja) 2012-02-02
US20050249756A1 (en) 2005-11-10
ES2249046T3 (es) 2006-03-16
AU763485B2 (en) 2003-07-24
MXPA01005816A (es) 2002-03-27
EP1137422A2 (en) 2001-10-04
HUP0104568A2 (hu) 2002-03-28
WO2000033869A3 (en) 2000-10-12
EP1137422B1 (en) 2005-09-14
GB9827104D0 (en) 1999-02-03
IL143296A (en) 2006-06-11
NO327044B1 (no) 2009-04-06
ATE304365T1 (de) 2005-09-15
JP2002531520A (ja) 2002-09-24
NO20012634L (no) 2001-08-08
PL201016B1 (pl) 2009-02-27
KR20010090874A (ko) 2001-10-19
US20120164099A1 (en) 2012-06-28
NO20012634D0 (no) 2001-05-29
CA2354045C (en) 2012-02-21
JP4949554B2 (ja) 2012-06-13
DE69927286D1 (de) 2005-10-20
DE69927286T2 (de) 2006-06-29
NZ512004A (en) 2003-08-29
CZ20012032A3 (cs) 2001-10-17
CZ300499B6 (cs) 2009-06-03
AU1668300A (en) 2000-06-26
IL143296A0 (en) 2002-04-21
US6972128B1 (en) 2005-12-06

Similar Documents

Publication Publication Date Title
SI1176964T1 (sl) Uporaba et743 za zdravljenje raka
IL129356A0 (en) Conjugates useful in the treatment of prostate cancer
HUP0104857A3 (en) New cancer treatments
IL136167A0 (en) Conjugates useful in the treatment of prostate cancer
IL124650A0 (en) Methods and therapeutic compositions for treating cancer
ZA9810974B (en) Conjugates useful in the treatment of prostate cancer
IL149281A0 (en) Treatment of cancer
GB9819999D0 (en) Treatment of cancer
GB9804361D0 (en) Cancer treatment
PL352681A1 (en) Preventive and therapeutic agents for cancer
AU5097099A (en) Methods and compositions for cancer treatment
GB0020261D0 (en) Therapeutic treatment
GB9827102D0 (en) New cancer treatments
AU2453399A (en) Bone cancer therapy
GB9903035D0 (en) Treating cancer
GB2334579B (en) Treating cancer
GB9818023D0 (en) Cancer treatment
GB9820000D0 (en) Cancer treatment
GB9818524D0 (en) Inorgasmia treatment
GB9826888D0 (en) Cervical cancer treatment
GB9802420D0 (en) Skin cancer alleviator
GB9908176D0 (en) Cancer treatment
GB9927106D0 (en) Cancer treatment
GB0007254D0 (en) Treating cancer
GB9914971D0 (en) Treating cancer

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees